The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. DexCom (DXCM) is a stock that can certainly grab the attention of ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common ...

Investors in DexCom Inc (Symbol: DXCM) saw new options begin trading this week, for the March 2024 expiration. One of the key data points that goes into the price an option buyer is willing to pay ...

DXCM stock declined 58.2% from a peak of $162.81 on 17 November 2021 to $67.99 on 16 June 2022, compared to a peak-to-trough drop of 25.4% for the S&P 500; ...

DexCom (DXCM) delivered earnings and revenue surprises of -3.03% and 1.99%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

DexCom (DXCM) closed the latest trading day at $134.56, indicating a -1.16% change from the previous session's end. The stock's change was more than the S&P 500's daily loss of 1.2%. Meanwhile ...

DexCom has a better P/E ratio of 65.84 than the aggregate P/E ratio of 53.6 of the Health Care Equipment & Supplies industry.

While DXCM may outperform ABT, it is helpful to see how Abbott’s Peers fares on metrics that matter. You will find other valuable comparisons for companies across industries at Peer Comparisons.